These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 31535848)

  • 21. Comprehensive in vitro cardiac safety assessment using human stem cell technology: Overview of CSAHi HEART initiative.
    Takasuna K; Asakura K; Araki S; Ando H; Kazusa K; Kitaguchi T; Kunimatsu T; Suzuki S; Miyamoto N
    J Pharmacol Toxicol Methods; 2017; 83():42-54. PubMed ID: 27646297
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 64 PI/PDMS hybrid cantilever arrays with an integrated strain sensor for a high-throughput drug toxicity screening application.
    Kim DS; Jeong YJ; Shanmugasundaram A; Oyunbaatar NE; Park J; Kim ES; Lee BK; Lee DW
    Biosens Bioelectron; 2021 Oct; 190():113380. PubMed ID: 34111727
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardiotoxicity screening with simultaneous optogenetic pacing, voltage imaging and calcium imaging.
    Dempsey GT; Chaudhary KW; Atwater N; Nguyen C; Brown BS; McNeish JD; Cohen AE; Kralj JM
    J Pharmacol Toxicol Methods; 2016; 81():240-50. PubMed ID: 27184445
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A cardiomyocyte-based biosensor for antiarrhythmic drug evaluation by simultaneously monitoring cell growth and beating.
    Wang T; Hu N; Cao J; Wu J; Su K; Wang P
    Biosens Bioelectron; 2013 Nov; 49():9-13. PubMed ID: 23708811
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of genomic biomarkers for anthracycline-induced cardiotoxicity in human iPSC-derived cardiomyocytes: an in vitro repeated exposure toxicity approach for safety assessment.
    Chaudhari U; Nemade H; Wagh V; Gaspar JA; Ellis JK; Srinivasan SP; Spitkovski D; Nguemo F; Louisse J; Bremer S; Hescheler J; Keun HC; Hengstler JG; Sachinidis A
    Arch Toxicol; 2016 Nov; 90(11):2763-2777. PubMed ID: 26537877
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human stem cell-derived cardiomyocytes detect drug-mediated changes in action potentials and ion currents.
    Gibson JK; Yue Y; Bronson J; Palmer C; Numann R
    J Pharmacol Toxicol Methods; 2014; 70(3):255-67. PubMed ID: 25219538
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug-induced functional cardiotoxicity screening in stem cell-derived human and mouse cardiomyocytes: effects of reference compounds.
    Himmel HM
    J Pharmacol Toxicol Methods; 2013; 68(1):97-111. PubMed ID: 23702537
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Universal and Sensitive Drug Assessment Biosensing Platform Using Optimal Mechanical Beating Detection of Single Cardiomyocyte.
    Xu D; Xiao H; Wang S; Li H; Chen HJ; Liu C; Hu N
    ACS Nano; 2022 Sep; 16(9):15484-15494. PubMed ID: 36094397
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Functional cardiotoxicity profiling and screening using the xCELLigence RTCA Cardio System.
    Xi B; Wang T; Li N; Ouyang W; Zhang W; Wu J; Xu X; Wang X; Abassi YA
    J Lab Autom; 2011 Dec; 16(6):415-21. PubMed ID: 22093298
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Real-Time Monitoring of Changes in Cardiac Contractility Using Silicon Cantilever Arrays Integrated with Strain Sensors.
    Dong M; Oyunbaatar NE; Kanade PP; Kim DS; Lee DW
    ACS Sens; 2021 Oct; 6(10):3556-3563. PubMed ID: 34554741
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interpretation of field potentials measured on a multi electrode array in pharmacological toxicity screening on primary and human pluripotent stem cell-derived cardiomyocytes.
    Tertoolen LGJ; Braam SR; van Meer BJ; Passier R; Mummery CL
    Biochem Biophys Res Commun; 2018 Mar; 497(4):1135-1141. PubMed ID: 28153730
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multifunctional 3D electrode platform for real-time in situ monitoring and stimulation of cardiac tissues.
    Zhang N; Stauffer F; Simona BR; Zhang F; Zhang ZM; Huang NP; Vörös J
    Biosens Bioelectron; 2018 Jul; 112():149-155. PubMed ID: 29702387
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhanced cardiomyocyte structural and functional anisotropy through synergetic combination of topographical, conductive, and mechanical stimulation.
    Kim J; Shanmugasundaram A; Lee CB; Kim JR; Park JJ; Kim ES; Lee BK; Lee DW
    Lab Chip; 2023 Oct; 23(20):4540-4551. PubMed ID: 37771289
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Moving beyond the comprehensive in vitro proarrhythmia assay: Use of human-induced pluripotent stem cell-derived cardiomyocytes to assess contractile effects associated with drug-induced structural cardiotoxicity.
    Yang X; Papoian T
    J Appl Toxicol; 2018 Sep; 38(9):1166-1176. PubMed ID: 29484688
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cardiotoxicity screening: a review of rapid-throughput in vitro approaches.
    Li X; Zhang R; Zhao B; Lossin C; Cao Z
    Arch Toxicol; 2016 Aug; 90(8):1803-16. PubMed ID: 26676948
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Electromechanical integrated recording of single cardiomyocyte in situ by multimodal microelectrode biosensing system.
    Zhang D; Xiang Y; Zou Q; Zhu K; Hu N
    Biosens Bioelectron; 2022 Sep; 212():114387. PubMed ID: 35635972
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phenotypic screening with human iPS cell-derived cardiomyocytes: HTS-compatible assays for interrogating cardiac hypertrophy.
    Carlson C; Koonce C; Aoyama N; Einhorn S; Fiene S; Thompson A; Swanson B; Anson B; Kattman S
    J Biomol Screen; 2013 Dec; 18(10):1203-11. PubMed ID: 24071917
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of FDSS/μCell imaging platform for preclinical cardiac electrophysiology safety screening of compounds in human induced pluripotent stem cell-derived cardiomyocytes.
    Zeng H; Roman MI; Lis E; Lagrutta A; Sannajust F
    J Pharmacol Toxicol Methods; 2016; 81():217-22. PubMed ID: 27222351
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacological response of human cardiomyocytes derived from virus-free induced pluripotent stem cells.
    Mehta A; Chung YY; Ng A; Iskandar F; Atan S; Wei H; Dusting G; Sun W; Wong P; Shim W
    Cardiovasc Res; 2011 Sep; 91(4):577-86. PubMed ID: 21565833
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Advances in Multidimensional Cardiac Biosensing Technologies: From Electrophysiology to Mechanical Motion and Contractile Force.
    Wei X; Zhuang L; Li H; He C; Wan H; Hu N; Wang P
    Small; 2020 Dec; 16(50):e2005828. PubMed ID: 33230867
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.